Markets:

Overview

News

Currencies

International

Treasuries

Seres Therapeutics, Inc. - Common Stock (NQ:MCRB)

17.10 -0.34 (-1.95%)

Streaming Delayed Price Updated: 3:23 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Seres Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Seres Therapeutics Announces Initiation of Enrollment in SER-155 Phase 1b Study Cohort 2 in Individuals Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

February 08, 2023

From Seres Therapeutics, Inc.

Via Business Wire

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 03, 2023

From Seres Therapeutics, Inc.

Via Business Wire

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 13, 2023

From Seres Therapeutics, Inc.

Via Business Wire

Recap: Seres Therapeutics Q3 Earnings ↗

November 02, 2022

Seres Therapeutics (NASDAQ:MCRB) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces SER-155 Phase 1b Study Progress

January 05, 2023

From Seres Therapeutics, Inc.

Via Business Wire

Seres Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

January 04, 2023

From Seres Therapeutics, Inc.

Via Business Wire

Charter Communications, Braze And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

December 14, 2022

U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. iQIYI, Inc. (NASDAQ: IQ) shares dipped 14.1% to $3.31 in...

Via Benzinga

Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket ↗

December 14, 2022

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI Bio.

Via Benzinga

Seres Therapeutics to Host Investor Webcast on December 8, 2022 to Discuss SER-109 Commercial Strategy

November 22, 2022

From Seres Therapeutics, Inc.

Via Business Wire

Seres Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates

November 02, 2022

From Seres Therapeutics, Inc.

Via Business Wire

Seres Therapeutics to Host Third Quarter 2022 Financial Results and Operational Progress Conference Call and Webcast on November 2, 2022

October 27, 2022

From Seres Therapeutics, Inc.

Via Business Wire

Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday ↗

October 31, 2022

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 26, 2022

Gainers

Via Benzinga

Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review

October 26, 2022

From Seres Therapeutics, Inc.

Via Business Wire

Seres Therapeutics Presents SER-109 ECOSPOR IV Study Data at IDWeek and American College of Gastroenterology (ACG) 2022 Annual Meetings

October 23, 2022

From Seres Therapeutics, Inc.

Via Business Wire

Seres Therapeutics’ ECOSPOR III Study Data on SER-109 Published in Journal of the American Medical Association

October 19, 2022

From Seres Therapeutics, Inc.

Via Business Wire

Seres Therapeutics to Present Clinical Results at IDWeek and American College of Gastroenterology (ACG) 2022 Annual Meeting

October 12, 2022

From Seres Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 20, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

September 20, 2022

Good morning, investor! It's time to start the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Via InvestorPlace

Ford, Evotec And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

September 20, 2022

U.S. stock futures traded lower this morning after recording gains in the previous session. Here are some big stocks moving lower in today’s pre-market trading session.

Via Benzinga

Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket ↗

September 20, 2022

Gainers

Via Benzinga

Seres Therapeutics to Present at World Anti-Microbial Resistance Congress

September 08, 2022

From Seres Therapeutics, Inc.

Via Business Wire

Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday ↗

September 08, 2022

Gainers

Via Benzinga

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗

September 07, 2022

Via Benzinga

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗

September 07, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.

Via Benzinga

Why Seres Therapeutics Shares Are Popping Off Today ↗

September 07, 2022

Seres Therapeutics Inc (NASDAQ: MCRB) shares are trading higher by 13.24% to $6.12 Wednesday morning after the company announced it completed the rolling submission process for its BLA to the FDA for...

Via Benzinga

Coupa Software, Glaukos And Some Other Big Stocks Moving Higher On Wednesday ↗

September 07, 2022

Via Benzinga

Seres Therapeutics Announces Completion of Rolling BLA Submission to FDA for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection

September 07, 2022

From Seres Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 10, 2022

Via Benzinga

Seres Therapeutics to Present at Canaccord Genuity 42nd Annual Growth Conference

August 04, 2022

From Seres Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.